MetaVia Inc. MetaVia Inc.

MetaVia Inc.

MTVA

Hisse Senetlerindeki Sıralama #32904
Headquartered in Cambridge, Massachusetts, MetaVia Inc. operates as a... Headquartered in Cambridge, Massachusetts, MetaVia Inc. operates as a clinical-stage biotechnology company with a core focus on discovering and commercializing novel pharmaceutical solutions for cardiometabolic disorders. Its leading investigational drug, DA-1241, a unique G-Protein-Coupled Receptor 119 agonist, is currently undergoing Phase 2a clinical trials for metabolic dysfunction-associated steatohepatitis (MASH). This follows the successful completion of Phase 1 trials for type 2 diabetes mellitus (T2DM), and the compound holds promise for use as both a standalone therapy and in combination treatments. Another significant asset, DA-1726, an innovative oxyntomodulin analogue that functions as a dual agonist for GLP-1 and glucagon receptors, is presently in preclinical development specifically for treating obesity. MetaVia's broader therapeutic pipeline also includes ANA001, a distinct oral niclosamide formulation intended for moderate COVID-19 patients; NB-01, designed to address painful diabetic neuropathy; NB-02, targeting cognitive impairment; and Gemcabene, for the management of dyslipidemia. The company engages in strategic partnerships, notably a licensing agreement with Pfizer Inc. for the research, development, manufacturing, and commercialization of Gemcabene. Additionally, a joint research collaboration with Dong-A ST and ImmunoForge supports the advancement of DA-1726. The entity adopted its current name, MetaVia Inc., in November 2024, transitioning from its former identity as NeuroBo Pharmaceuticals, Inc.
Hisse Fiyatı
$1.28
Son senkronizasyon: 2026-10-20
Piyasa Değeri
$8.43M
Değişim (1 gün)
4.07%
Değişim (1 yıl)
-21.47%
Ülke
US
Ticaret MetaVia Inc. (MTVA)

Kategori

Healthcare
MetaVia Inc. (MTVA) için hisse bölünme geçmişi
MetaVia Inc. hissesi (sembol: MTVA) toplamda 3 hisse bölünmesi yaşamıştır.
En son hisse bölünmesi Dec 21, 2023 tarihinde gerçekleşmiştir.
Dec 31, 2019 tarihinden önce alınan bir MTVA hissesi bugün 0.00016666666666667 MTVA hissesine eşdeğerdir.
Hisse bölünme listesi
Yıl Bölünme Çarpan Kümülatif Çarpan
2023-12-21 1:8 x0.125 x0.00016666666666667
2022-09-13 1:30 x0.033333333333333 x0.0013333333333333
2019-12-31 1:25 x0.04 x0.04
Benzer şirketler veya rakipler için hisse bölünmeleri
Şirket Hisse bölünme sayısı Kümülatif Çarpan Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL